2009 Annual Meeting | Contemporary Clinical Issues Plenary Session
| 09:00 AM - 12:00 PM |
Break
|
|
| 09:00 AM - 12:00 PM |
Abstract Presenter: Parental Dementia and Alzheimer Disease Are Associated with Poorer Memory in Middle-Aged Adults: The Framingham Offspring Study
Stephanie Debette, MD, PhD |
|
| 09:00 AM - 12:00 PM |
Discussant: Parental Dementia and Alzheimer Disease Are Associated with Poorer Memory in Middle-Aged Adults: The Framingham Offspring Study
David A. Bennett, MD |
|
| 09:00 AM - 12:00 PM |
Abstract Presenter: Inclusion of Women of Childbearing Potential (WOCBP) in Clinical Trials with Neurologic Diseases and Procedures
Barbara P. Karp, MD, FAAN |
|
| 09:00 AM - 12:00 PM |
Discussant: Inclusion of Women of Childbearing Potential (WOCBP) in Clinical Trials with Neurologic Diseases and Procedures
Karl D. Kieburtz, MD |
|
| 09:00 AM - 12:00 PM |
Sudden Unexplained Death in Epilepsy
Elizabeth Donner, MD, FRCPC |
|
| 09:00 AM - 12:00 PM |
Use of mTOR Inhibitors in the Treatment of Tuberous Sclerosis Complex
David N. Franz, MD |
|
| 09:00 AM - 12:00 PM |
Can the Sunshine Vitamin Throw Light on MS? The Case for Vitamin D in MS Prevention
Alberto Ascherio, MD, PhD |
|
| 09:00 AM - 12:00 PM |
Extending the Time Window for Thrombolytic Therapy for Acute Stroke
Patrick D. Lyden, MD, FAAN |
| Barbara P. Karp, MD, FAAN | Dr. Karp has received personal compensation in the range of $500-$4,999 for serving as a Faculty for a course on chemodenervation with Catalyst Medical 好色先生. |
| Karl D. Kieburtz, MD | Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation. |
| Alberto Ascherio, MD, PhD | The institution of Dr. Ascherio has received research support from NIH and US Department of Defense . |
| David A. Bennett, MD | Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Origent. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Study section, DMC, NACA Council with NIH. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a invited lectures with AMCs. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a invited paper with National Academy of Sciences. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a lecture with National Academy of Neuropsychology. |
| Stephanie Debette, MD, PhD | No disclosure on file |
| Elizabeth Donner, MD, FRCPC | Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seizure. The institution of Dr. Donner has received research support from SickKids Centre for Brain and Mental Health. The institution of Dr. Donner has received research support from Ontario Brain Institute. The institution of Dr. Donner has received research support from CIHR. |
| David N. Franz, MD | No disclosure on file |
| Patrick D. Lyden, MD, FAAN | Dr. Lyden has received personal compensation for serving as an employee of University of Southern Californiaq. Dr. Lyden has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apex Innovations. Dr. Lyden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harvard Clinical Research Institue. Dr. Lyden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Lyden has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Cerebral Blood Flow and Metabolism. Dr. Lyden has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various. The institution of Dr. Lyden has received research support from NINDS. Dr. Lyden has received publishing royalties from a publication relating to health care. |